Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

88.40USD
21 Feb 2017
Change (% chg)

$-0.10 (-0.11%)
Prev Close
$88.50
Open
$88.60
Day's High
$89.00
Day's Low
$87.96
Volume
74,904
Avg. Vol
122,321
52-wk High
$89.58
52-wk Low
$67.21

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices and therapies. The Company operates through three segments: Research Models and Services... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $4,187.77
Shares Outstanding(Mil.): 47.37
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 27.46 47.00 29.32
EPS (TTM): 3.22 -- --
ROI: 7.82 -4.07 13.03
ROE: 19.68 4.71 14.17

BRIEF-Charles River Laboratories reports Q4 GAAP earnings per share $0.93

Feb 14 Charles River Laboratories International Inc

Feb 14 2017

BRIEF-Charles river laboratories Q3 GAAP earnings per share $0.78

Nov 2 Charles River Laboratories International Inc :

Nov 02 2016

BRIEF-Charles River extends integrated discovery program with Genentech

Oct 11 Charles River Laboratories International Inc

Oct 11 2016

BRIEF-Charles River Labs says acquires Agilux Labs for $64 mln

Sept 28 Charles River Laboratories International Inc

Sep 28 2016

More From Around the Web

Earnings vs. Estimates